P. Bonney

发表

Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.

D. Dhawan, J. Ramos-Vara, D. Knapp, 2014, ILAR journal.

Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer.

L. Glickman, D. Knapp, P. Bonney, 2000, Urologic oncology.

Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.

D. Knapp, G. Moore, P. Bonney, 2011, Journal of the American Veterinary Medical Association.

Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder.

P. Snyder, D. Knapp, P. Bonney, 2005, Veterinary and comparative oncology.

Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs

D. Jones, D. Dhawan, D. Knapp, 2017, Veterinary and comparative oncology.

Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.

D. Knapp, P. Bonney, M. Childress, 2013, Journal of the American Veterinary Medical Association.

Evaluation of the effect of dietary vegetable consumption on reducing risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers.

L. Glickman, D. Knapp, P. Bonney, 2005, Journal of the American Veterinary Medical Association.

Detection of herbicides in the urine of pet dogs following home lawn chemical application.

A. Murphy, L. Glickman, D. Knapp, 2013, The Science of the total environment.

Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs.

D. Knapp, P. Bonney, N. Glickman, 2002, Journal of the American Veterinary Medical Association.

Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer

T. Kuczek, L. Glickman, D. Knapp, 2000, Cancer Chemotherapy and Pharmacology.

Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.

P. Snyder, P. Bonney, N. Glickman, 2005, Prostaglandins, leukotrienes, and essential fatty acids.

Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

B. Craig, P. Snyder, D. Knapp, 2002, Cancer research.

Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.

T. Kuczek, D. Knapp, P. Bonney, 1994, Journal of veterinary internal medicine.

Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985-2010).

J. Ramos-Vara, D. Knapp, P. Bonney, 2013, Journal of the American Veterinary Medical Association.

Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.

Kean Ming Tan, D. Knapp, P. Bonney, 2011, Journal of veterinary internal medicine.

Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma

Sagar M. Utturkar, E. Ostrander, H. Parker, 2022, Frontiers in Oncology.

Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers.

L. Glickman, D. Knapp, P. Bonney, 2004, Journal of the American Veterinary Medical Association.

Antibodies to Canine Granulocyte Colony-stimulating Factor Induce Persistent Neutropenia

T. Boone, P. Bonney, W. Reagan, 1995, Veterinary pathology.

Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer—Evidence for a Relevant Model System and Urine-Based Diagnostic Test

E. Ostrander, E. Kwon, E. Karlins, 2015, Molecular Cancer Research.

Outcome of urethral stent placement for management of urethral obstruction secondary to transitional cell carcinoma in dogs: 19 cases (2007-2010).

J. Ramos-Vara, D. Knapp, P. Bonney, 2012, Journal of the American Veterinary Medical Association.

Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development.

E. Ostrander, E. Kwon, H. Parker, 2011, The Journal of urology.

Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.

D. Knapp, P. Bonney, M. D. Lucroy, 2007, Journal of the American Veterinary Medical Association.

Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).

D. Knapp, P. Bonney, N. Glickman, 1996, Journal of the American Veterinary Medical Association.

Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?

P. Bonney, W. Carlton, R. Teclaw, 1992, Journal of veterinary internal medicine.

Canine anal sac adenocarcinomas: clinical presentation and response to therapy.

D. Knapp, P. Bonney, N. Glickman, 2002, Journal of veterinary internal medicine.

Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.

R. Sellers, D. Knapp, P. Bonney, 2004, Prostaglandins, leukotrienes, and essential fatty acids.

Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.

J. Ramos-Vara, D. Knapp, G. Moore, 2013, Journal of veterinary internal medicine.

Cisplatin therapy in 41 dogs with malignant tumors.

D. Knapp, P. Bonney, K. Hahn, 1988, Journal of Veterinary Internal Medicine.

Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

B. Craig, P. Snyder, D. Knapp, 2003, Molecular cancer therapeutics.

Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma.

D. Knapp, P. Bonney, M. D. Lucroy, 2005, Journal of the American Animal Hospital Association.

NMR-based metabolomics study of canine bladder cancer.

D. Raftery, D. Knapp, P. Bonney, 2012, Biochimica et biophysica acta.

Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.

D. Knapp, P. Bonney, N. Glickman, 2002, Journal of the American Animal Hospital Association.

Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer

B. Craig, D. Dhawan, J. Ramos-Vara, 2015, PloS one.

Topical flea and tick pesticides and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers.

L. Glickman, D. Knapp, P. Bonney, 2004, Journal of the American Veterinary Medical Association.

Near infrared imaging to identify sentinel lymph nodes in invasive urinary bladder cancer

Larry G. Adams, Jose Ramos-Vara, John V. Frangioni, 2006, SPIE BiOS.

Review article Naturally-occurring canine transitional cell carcinoma of the urinary bladder A relevant model of human invasive bladder cancer

L. Glickman, D. Knapp, P. Bonney, 2000 .

Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer.

D. Knapp, P. Bonney, N. Glickman, 2002, Advances in experimental medicine and biology.

Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer

B. Craig, D. Dhawan, J. Ramos-Vara, 2015, PloS one.